PIERIS PHARMACEUTICALS, INC. 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Aug 18, 2015
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Award
Common Stock
2015-08-17+500,000→ 500,000 totalExercise: $3.36Exp: 2025-08-17→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on August 17, 2016 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter until August 17, 2019.